ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,440Medicare Part D Prescriptions Filled, Including Refills

Rank: 42 out of 337

$514K Total Retail Price of All Prescriptions

Rank: 71 out of 337

552 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
23% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

7% of this provider’s 552 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

2% of this provider’s 10,786 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$41 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
SIMVASTATIN 1,011 947 1 1
LISINOPRIL 703 642 2 2
HYDROCHLOROTHIAZIDE 626 589 3 9
AMLODIPINE BESYLATE 518 494 4 3
OMEPRAZOLE 418 379 5 4
ATORVASTATIN CALCIUM 405 384 6 7
LEVOTHYROXINE SODIUM 364 319 7 5
METOPROLOL TARTRATE 342 304 8 6
CITALOPRAM HBR 271 230 9 17
ATENOLOL 221 197 10 10
TRAZODONE HCL 217 203 11 16
RANITIDINE HCL 210 192 12 30
PRAVASTATIN SODIUM 210 182 12 14
LOVASTATIN 191 183 14 24
LISINOPRIL-HYDROCHLOROTHIAZIDE 189 189 15 31
LOSARTAN POTASSIUM 187 187 16 15
FUROSEMIDE 184 166 17 8
WARFARIN SODIUM 178 170 18 11
METFORMIN HCL 158 137 19 12
DIOVAN 154 141 20 26
GABAPENTIN 141 108 21 20
LOSARTAN-HYDROCHLOROTHIAZIDE 120 120 22 60
GLYBURIDE 116 91 R 23 53
METOPROLOL SUCCINATE 116 98 23 21
SERTRALINE HCL 105 99 25 18
LIPITOR 105 105 25 33
DONEPEZIL HCL 100 88 27 22
ALLOPURINOL 99 99 28 28
TRIAMTERENE-HCTZ 99 89 28 39
JANUVIA 95 61 30 81
SYNTHROID 95 93 30 41
ENALAPRIL MALEATE 95 92 30 37
ZOLPIDEM TARTRATE 91 68 33 23
HYDROCODONE-ACETAMINOPHEN 86 64 S3 34 13
EVISTA 85 85 35 102
ZETIA 83 71 36 89
ALENDRONATE SODIUM 80 80 37 19
FLUTICASONE PROPIONATE 77 62 38 34
DIOVAN HCT 77 64 38 88
TAMSULOSIN HCL 77 74 38 25
PANTOPRAZOLE SODIUM 77 71 38 36
POLYETHYLENE GLYCOL 3350 70 43 42 47
FENOFIBRATE 69 67 43 48
CRESTOR 66 53 44 29
FLUOXETINE HCL 64 26 45 57
GLYBURIDE-METFORMIN HCL 60 60 R 46 99
TRICOR 58 48 47 134
MECLIZINE HCL 54 54 48 117
ALPRAZOLAM 52 50 49 78
PROAIR HFA 52 50 49 38
PLAVIX 50 50 51 74
KLOR-CON M20 50 47 51 65
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 4, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.